Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;62(8):2239-48.
doi: 10.1002/art.27533.

Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis

Affiliations

Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis

Altan Ercan et al. Arthritis Rheum. 2010 Aug.

Abstract

Objective: To examine the association between aberrant IgG galactosylation and disease parameters in rheumatoid arthritis (RA).

Methods: Analysis of N-glycan in serum samples from multiple cohorts was performed. The IgG N-glycan content and the timing of N-glycan aberrancy relative to disease onset were compared in healthy subjects and in patients with RA. Correlations between aberrant galactosylation and disease activity were assessed in the RA cohorts. The impact of disease activity, sex, age, anti-cyclic citrullinated peptide (anti-CCP) antibody titer, disease duration, and C-reactive protein level on aberrant galactosylation was determined using multivariate analysis. The N-glycan content was also compared between epitope affinity-purified autoantibodies and the remaining IgG repertoire in RA patients.

Results: Our results confirm the aberrant galactosylation of IgG in RA patients as compared with healthy controls (mean +/- SD 1.36 +/- 0.43 versus 1.01 +/- 0.23; P < 0.0001). We observed a significant correlation between levels of aberrant IgG galactosylation and disease activity (Spearman's rho = 0.37, P < 0.0001). This correlation was higher in women (Spearman's rho = 0.60, P < 0.0001) than in men (Spearman's rho = 0.16, P = 0.10). Further, aberrant IgG galactosylation substantially predated the onset of arthritis and the diagnosis of RA (3.5 years) and resided selectively in the anticitrullinated antigen fraction.

Conclusion: Our findings identify aberrant IgG galactosylation as a dysregulated component of the humoral immune response in RA that begins prior to disease onset, associates with disease activity in a sex-specific manner, and resides preferentially in autoantibodies.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Oligosaccharide structures attached to Asp-297 of IgG
Shown are fully galactosylated (G2, FA2BG2), monogalactosylated (G1, FA2[6]BG1) and agalactosylated (G0, FA2B) form of the biantennary oligosaccharide attached to the CH2 Fc region of IgG (67). In this nomenclature, since all N-glycans have two core GlcNAc residues, a F at the start of the abbreviation indicates a core fucose in α1-6 linkage to the inner GlcNAc. A2 denotes a biantennary structure with both GlcNAcs β1-2 linked. B symbolizes a bisecting GlcNAc linked β1-4 to β1-3 mannose. Gx communicates the number of β1-4 linked galactose residues on each antenna. Here, [6]G1 indicates that the galactose is on the antenna of the α1-3 or α1-6 mannose.
Figure 2
Figure 2. IgG galactosylation (sG0/G1) ratios are aberrant in RA and this aberrancy precedes disease onset
A, sG0/G1 ratios for RA subjects (N = 232) and gender-matched controls (N = 232) were determined using the in-gel digest assay on whole serum (44). Individual values as well as averages for RA subjects and healthy donors are shown. (P < 0.0001). B, sG0/G1 ratios were determined in a longitudinal series of healthy and pre- and post-disease onset serum samples in the DoDSR cohort. Shown are mean and SEM values for subjects with RA (red and black) and age- and gender-matched healthy controls (blue and green). Values are reported longitudinally relative to onset of disease in the RA cohort. Note the sG0/G1 ratios between healthy and disease subjects diverge significantly ~3.5 years prior to disease onset.
Figure 3
Figure 3. sG0/G1 ratios in anti-citrulline autoantibodies vs. repertoire IgG
Shown are sG0/G1 ratios of IgG autoantobodies reactive to the citrullinated JED autoantigen and residual repertoire IgG after epitope affinity removal of anti-JED autoantibodies. Symbols portray individual subject values. Horizontal lines denote average values. (P=0.006).

Similar articles

Cited by

References

    1. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis and rheumatism. 2000;43(1):155–163. - PubMed
    1. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002;4(2):87–93. - PMC - PubMed
    1. Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ. Anti-keratin antibodies in rheumatoid arthritis. Br Med J. 1979;2(6182):97–99. - PMC - PubMed
    1. Blass S, Specker C, Lakomek HJ, Schneider EM, Schwochau M. Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies. Ann Rheum Dis. 1995;54(5):355–360. - PMC - PubMed
    1. Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, Wooley P, et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol. 2001;166(3):1492–1498. - PubMed

Publication types